LGC reports half year trading in line with expectations

News - Update for the half year ended 30 September 2021

23 December 2021
LGC publishes ESG report for 2020-21

News - LGC's first ESG report using GRI Standards, the most widely used sustainability reporting framework 

01 December 2021
LGC to develop new Berlin site to expand Nucleic Acid Therapeutics capacity

News - Site will be dedicated to medium to large scale and early to late Phase Clinical GMP manufacturing of Nucleic Acid Therapeutics

15 November 2021
LGC’s commitment to carbon net zero

News - LGC is committing to being carbon net zero by 2050

10 November 2021
LGC supports British Pharmacopoeia 2022

Blog - LGC’s MHRA Laboratories Team supports the annual BP publication by providing physico-chemical analysis of substances

04 November 2021
LGC, Biosearch Technologies testing workflow underpins expansion of COVID-19 testing in New York

News - Nexar workflow continues to enable simple, scalable, and cost-effective testing 

29 October 2021
LGC instruments support important milestones

Blog - LGC’s validated technology provides gold-standard sensitivity and specificity based on clinical data, as well as material cost and time savings.

25 October 2021
World Standards Day 2021

Blog - On 14th October, we celebrate World Standards Day. Documentary standards provide an agreed “best way of doing things”, based on expert knowledge and best practice from across the world.

14 October 2021
Measurement science improves standardisation of SARS-CoV-2 quantification

News - NML team analysis vital to understanding potential discrepancies in measured viral burden used to manage CoVid-19 pandemic

12 October 2021
LGC's "incredibly critical" ultra-high-throughput CoVid workflow spotlighted in GenomeWeb

Blog - Mark Dearden recently spoke with GenomeWeb to discuss CoVid workflow and much more besides

30 September 2021